Jean‐Philippe Spano
Inserm(FR)Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Pitié-Salpêtrière Hospital(FR)Institut Pierre Louis d‘Épidémiologie et de Santé Publique(FR)Hôpital Charles-Foix(FR)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Viral-associated cancers and disorders, Cancer Treatment and Pharmacology, Epigenetics and DNA Methylation, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study(2018)1,149 cited
- → Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer(2021)702 cited
- → Impact of EGFR expression on colorectal cancer patient prognosis and survival(2004)461 cited
- → Management of hypertension in angiogenesis inhibitor-treated patients(2009)344 cited
- → Surgery in reference centers improves survival of sarcoma patients: a nationwide study(2019)316 cited
- → Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study(2008)